Biotechnology company
2 AI-extracted insights from 1 source — podcasts, YouTube channels, and X/Twitter accounts.
Not enough scored insights about SKYE Bioscience Inc. in the last 30 days yet.
The 1 sources with the most insights about SKYE Bioscience Inc. on Kazuha.
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
A 10% owner made an unscheduled sale of $800,000 after the stock gained almost 60%. The last time this insider sold, the stock fell over 40% in the following three months, making this a strong bearish signal.
A 10% owner sold $800,000 of stock after a nearly 60% run-up. The insider's only previous sale was followed by a 40% drop in the stock, representing a strong bearish signal.
A 10% owner made an unscheduled sale of $800,000 after the stock gained almost 60%. The last time this insider sold, the stock fell over 40% in the following three months, making this a strong bearish signal.
A 10% owner sold $800,000 of stock after a nearly 60% run-up. The insider's only previous sale was followed by a 40% drop in the stock, representing a strong bearish signal.
Other assets that creators frequently mention in the same content as SKYE Bioscience Inc..
The most active sources covering SKYE Bioscience Inc. (SKYE) on Kazuha are @ceowatcher. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
Kazuha has indexed 2 AI-extracted insights about SKYE Bioscience Inc. (SKYE) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
Creators covering SKYE Bioscience Inc. (SKYE) most frequently also discuss COTY, NTLA, HD, INFI, SATL. See the "Discussed alongside" section above for full asset pages.